濡絾鐗犻妴锟�
闁哄牏鍠庨崹锟�: 鐎甸偊鍠曟穱濠囧棘閸モ晝褰� 闁革负鍔庨崵搴㈢▕閿斿墽娼� 閻犙冨閺嬧剝绋夌€n厽绁� 闁稿鍎遍幃宥夊级閸屾氨绠� 闁硅翰鍎遍崹鏃堟焻婢跺瞼妞� 闁糕晞娅i、鍛村礌鐠囧樊鍔� 濞戞挻娼欑花銉╁礌鐠囧樊鍔� 闁肩瓔鍨伴锟� 閻庢冻闄勬慨锟� 濞戞搩鍘煎ù妤呭礌鐠囧樊鍔� 闁告鍋嗛弫鎾诲箑閺勫浚鍟�
濞e洦绻傛禒锟�: 闁哄倷鍗冲锟� 閻犲洤瀚锟� 閻熸瑥妫涢崑锟� 閻㈩垱鐡曢惁锟� 闁汇倕澧藉锟� 闁汇儱娲ㄦ慨锟� 闁稿繗宕甸弫锟� 闁烩偓鍔忓畵锟� 闁硅翰鍊楅幃锟� 闁诡兙鍎查弲锟� 闁稿鍎撮棅锟� 缂傚洤楠搁锟� 濞戞挶鍊栭埀顒婃嫹 闁煎弶褰冮崝锟� 闁活澁鎷� 濠靛偊鎷� 闁煎府鎷� 閻忓骏鎷� 闁搞儲绋戦锟� 閻犲洩宕垫晶锟� 闁哄洦娼欓ˇ锟�
濞戞搩鍘肩亸锟�: 閻㈩垱鐡曢惁锟� 闁轰焦鐟﹀ḿ锟� 闁诡剚绻嗛埀顒婃嫹 濞戞搩鍙€瀹擄拷 闁告牞宕甸幃锟� 濞戞挻娼欑花锟� 闂佽棄鐗撻锟� 婵ɑ鍨跺Λ锟� 闁哄倸娲ょ€碉拷 闁戒焦銇炵紞锟� 濡ょ姴鏈弻锟� 闁搞儲宕樺锟� 濡炲鍠撻弸锟� 闁肩瓔鍨虫晶锟� 闁肩瓔鍨粭锟� 闁肩瓔鍨扮粩锟� 闁哄倹濯藉畵锟� 闁瑰吋绮庨崒锟� 闁兼槒椴搁弸锟�
当前位置: 首页 > 期刊 > 《新英格兰医药杂志》 > 2006年第15期 > 正文
编号:11329996
Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
http://www.100md.com 《新英格兰医药杂志》

     To the Editor: Shankaran et al. (Oct. 13 issue)1 report improved neurologic outcomes and reduced mortality in newborns with perinatal asphyxia treated with mild hypothermia. This confirms previous observations from one randomized trial and eight nonrandomized studies.2,3

    The accompanying editorial by Papile4 concludes that brain cooling for neonates with hypoxic–ischemic encephalopathy should be considered an experimental technique and that widespread application would be premature. Papile suggests that longer-term follow-up will be needed to confirm the benefits in terms of neurologic performance. We feel strongly that this conservatism is misplaced. No other effective treatments for encephalopathy after hypoxia are available; with two randomized trials and eight nonrandomized studies all showing benefits from hypothermia without significant adverse events, and with supporting evidence from studies of other conditions,3,5 particularly encephalopathy after hypoxia subsequent to cardiac arrest, how much more evidence is needed?

    The effectiveness of hypothermia depends on speed of induction3,5; indeed, "time is brain." Obtaining informed consent will cause a loss of precious time. Although obtaining consent is unavoidable for unproven treatments, it should no longer apply to the treatment of encephalopathy after hypoxia. Physicians caring for patients with hypoxic encephalopathy should begin offering this treatment immediately.

    Kees H. Polderman, M.D., Ph.D.

    Armand R.J. Girbes, M.D., Ph.D.

    Vrije Universiteit Medical Center

    1007 MB Amsterdam, the Netherlands

    k.polderman@tip.nl

    References

    Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005;353:1574-1584.

    Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005;365:663-670.

    Polderman KH. Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. 1. Indications and evidence. Intensive Care Med 2004;30:556-575.

    Papile L-A. Systemic hypothermia -- a "cool" therapy for neonatal hypoxic-ischemic encephalopathy. N Engl J Med 2005;353:1619-1620.

    Polderman KH. Application of therapeutic hypothermia in the intensive care unit: opportunities and pitfalls of a promising treatment modality. 2. Practical aspects and side effects. Intensive Care Med 2004;30:757-769.

    To the Editor: Shankaran and colleagues report that whole-body hypothermia reduces the risk of death or disability in infants with hypoxic–ischemic encephalopathy. Their article, however, may have contributed to perpetuating misinterpretations about the etiology of encephalopathy in newborns.

    Their chief criterion for study entry was marked acidosis, which can be due to hypoxia or ischemia but can have other antecedents. Only a small proportion of cases of encephalopathy in term infants is attributable to identifiable perinatal catastrophes.1,2 The neutral term "neonatal encephalopathy" does not claim more than the evidence supports and is clearly more suitable than "hypoxic–ischemic encephalopathy" when the etiology is uncertain.

    Appropriate terminology matters. Methods of prevention are likely to differ according to the etiology of the encephalopathy. In addition, the diagnosis of hypoxic–ischemic encephalopathy by the physician can be used to blame obstetrical caregivers, even when the processes leading to brain injury were present some time before birth and were not recognizable or alterable by the obstetrician. A diagnosis of hypoxic–ischemic encephalopathy should be made only when there is clear evidence to justify it. The preferable term is neonatal encephalopathy.

    (The views expressed are those of the authors and do not necessarily represent those of the National Institutes of Health or the Department of Health and Human Services.)

    Karin B. Nelson, M.D.

    National Institute of Neurological Disorders and Stroke

    Bethesda, MD 20892-1447

    Alan Leviton, M.D.

    Children's Hospital Boston

    Boston, MA 02215-5393

    alan.leviton@childrens.harvard.edu

    References

    Nelson KB, Leviton A. How much of neonatal encephalopathy is due to birth asphyxia? Am J Dis Child 1991;145:1325-1331.

    Badawi N, Felix JF, Kurinczuk JJ, et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol 2005;47:293-298.

    To the Editor: The article by Shankaran et al. about systemic hypothermia in newborns adds critical weight to previous reports that post-injury hypothermia may improve the recovery of infants with neonatal encephalopathy. Although the magnitudes of the effect, adjusted for the severity of clinical encephalopathy, are similar in the present report and in a trial we reported previously,1 it is intriguing to note one apparent difference. In the trial of head cooling, there was no effect on mortality in the first week of life, whereas neuromotor disability at 18 months was reduced; in the trial of systemic cooling, a substantial component of the overall improvement in final outcome was a reduction in early mortality. There is some evidence from early magnetic resonance imaging (MRI) of infants cooled by both methods that suggests that the cortex is much better protected by head cooling than by systemic hypothermia, although deep-brain structures appeared similarly protected.2

    Thus, it may be that long-term follow-up will demonstrate a difference in cognitive or other outcomes. Further work is essential to identify the optimal methods of applying hypothermia and selecting infants who may benefit from treatment.

    Peter D. Gluckman, F.R.S.

    Alistair J. Gunn, M.B., Ch.B., Ph.D.

    University of Auckland

    Auckland 1020, New Zealand

    aj.gunn@auckland.ac.nz

    John S. Wyatt, M.B., Ch.B.

    University College London

    London WC1E 6BT, United Kingdom

    References

    Gunn AJ, Gluckman PD, Wyatt JS, Thoresen M, Edwards AD. Selective head cooling after neonatal encephalopathy. Lancet 2005;365:1619-1620.

    Rutherford MA, Azzopardi D, Whitelaw A, et al. Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy. Pediatrics 2005;116:1001-1006.

    The authors reply: As noted by Polderman and Girbes, treatment for hypoxic–ischemic encephalopathy currently is limited to supportive intensive care, and our study demonstrated the efficacy of whole-body cooling in reducing the rate of death or disability in infants with moderate or severe encephalopathy. We are currently cooling infants in our network centers if the infants meet the same criteria as for study entry. We also use a protocol identical to the study protocol. We believe, however, that caution must be exercised before whole-body hypothermia can be used in routine clinical practice. Use of the equipment requires skilled personnel, and the infants require continuous monitoring during the cooling and rewarming process.

    We agree with Nelson and Leviton that only a proportion of newborn encephalopathy is attributable to hypoxia and ischemia. The subgroup of neonates with encephalopathy after hypoxia and ischemia comprises infants who may benefit from hypothermia, given the efficacy of this intervention in studies in animals.1,2,3 The eligibility criteria for this trial were designed to be consistent with acute hypoxic–ischemic encephalopathy supported by profound fetal acidosis or acute perinatal events and resuscitation at birth. We reviewed the diagnosis at discharge or death of the 205 study infants with primary outcome data, and 4 infants (2 in the hypothermia group and 2 in the control group) were confirmed after randomization to have sepsis. No metabolic or major congenital abnormalities that contributed to encephalopathy were diagnosed in any study infant.

    We respectfully disagree with the statement by Gluckman et al. that a substantial component of the overall improvement in the final outcome of our study was a reduction in early mortality. The rate of the primary outcome of our study (death or moderate or severe disability at 18 to 22 months of age) was significantly lower in the hypothermia group than in the control group. For the secondary outcome of death before 18 months, the relative risk in the hypothermia group, as compared with the control group, was 0.68 (95 percent confidence interval, 0.44 to 1.05; P=0.08). The frequency of neuromotor impairment was similar in our study and the Cool Cap study by Gunn et al.4 In our study, disabling cerebral palsy occurred in 19 percent of infants in the hypothermia group and 30 percent of infants in the control group. In the Cool Cap study, severe neuromotor disability occurred in 19 percent of the cooled infants and 31 percent of the control infants. Our study differs from the Cool Cap study in the following areas: eligibility criteria (we did not use the amplitude-integrated electroencephalograph), method of cooling (whole body in our study as compared with selective head cooling in the Cool Cap study), and the target temperature (33.5°C in our study as compared with 34° to 35°C in the Cool Cap study). We also suggest that patterns of brain injury on MRI for infants undergoing head or body cooling remain unresolved; MRI shows that systemic hypothermia provides protection of the cortex with cooling.5 We will examine our study subjects at school age to determine the long-term effects of cooling therapy.

    Seetha Shankaran, M.D.

    Wayne State University

    Detroit, MI 48201

    sshankar@med.wayne.edu

    Abbot R. Laptook, M.D.

    Women and Infants Hospital

    Providence, RI 02905

    for the National Institute of Child Health and Human Development Neonatal Research Network

    References

    Busto R, Dietrich WD, Globus MYT, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987;7:729-738.

    Laptook AR, Corbett RJT, Sterett R, Burns DK, Garcia D, Tollefsbol G. Modest hypothermia provides partial neuroprotection when used for immediate resuscitation after brain ischemia. Pediatr Res 1997;42:17-23.

    Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 1997;99:248-256.

    Gunn AJ, Gluckman PD, Wyatt JS, Thoresen M, Edwards AD. Selective head cooling after neonatal encephalopathy. Lancet 2005;365:1619-1620. e]

    Inder TE, Hunt RW, Morley CJ, et al. Randomized trial of systemic hypothermia selectively protects the cortex on MRI in term hypoxic-ischemic encephalopathy. J Pediatr 2004;145:835-837.
    濞e洠鍓濇导鍛閸涱剛杩旈柛娆忓€介埀顒€鍠涚槐婵囩▔瀹ュ棛鈧垶骞嬮幇顏呭床濞达絾娲戠粻锝咁嚈妤︽鍞撮柕鍡曠劍鐢綊鎳¢幇顓炵仐闁圭ǹ娲ょ槐鈺呭Υ閸屾稒鐎紒鏃傚Х婢ф寮堕崘銊ф剑濞存粌楠哥敮顐︽媼濡炲墽绋婇柡澶婂暕濮瑰鏁嶅畝鍐仧闁诡喓鍔忛缁樼▔閻戞﹩鍔冮柡鍌氭矗缁楀鈧绮忛~锕傚绩鐠鸿櫣绉垮〒姘☉閵囧洨鈧娉涢崢銈囨嫻瑜版帗顫夐悹鍥︾串缁辨繄鎷犻悜钘変粡濞寸姾鍩栭崹銊╂偨娴e啰妯堥梺顐f皑閻擄繝骞嬮幋婊勭拨闁挎稑鏈崹婊勭椤掍焦鏆柛鎺嶅嵆閳ь剚姘ㄩ悡锟犲触鎼搭垳绀夊ù鍏兼皑閻濇盯宕¢崘鑼闁诡喓鍔庡▓鎴炴媴濠婂啯鎯傚ù鐘插濠€鎵磾閹寸姷褰查柛鎺斿█濞呭酣濡撮敓锟�

   鐎甸偊鍠曟穱濠囧棘閸モ晝褰�  闁稿繗娅曢弫鐐烘儌閻愵剙顎�  閻犲洤瀚鎴﹀礄閻樻彃缍�  闁瑰吋绮庨崒銊╁即閺夋埈妯�   闁规亽鍔岄悺銊х磼濞嗘劖绠欓柛娆欐嫹   闁告梻濮撮崣鍡涘绩閹増顥�